Treatment with mesenchymal stem cells increases hepatic anti-apoptotic gene expression
Mesenchymal stem cell (MSC) therapy shows promise in liver disease. Our study reveals increased hepatic anti-apoptotic gene expression following MSC treatment, suggesting a novel therapeutic mechanism for mitigating liver injury and promoting regeneration. Learn more about our findings.